New Approve Drug For Covid-19

While the world await the vaccine to cure the novel virus flying like a rumour news, while all Countries empowered there laboratory to get a final defeat to the virus.

Dexamethasone was out-flag on Tuesday as the only drug to reduce the high death of Covid-19 victim in trial results hailed as a “major breakthrough” in the fight against the disease.

Britain’s Health Secretary Matt Hancock said the country’s patients would start to receive the drug immediately.

Daily doses of the steroid could prevent one-in-eight ventilated patient deaths and save one out of every 25 patients requiring oxygen alone, the team said.

The trial, carried out by the RECOVERY research group that is searching for effective COVID-19 treatments, included a control group of 4,000 patients who did not receive the drug.

“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford.

“Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”

“This is a major breakthrough: dexamethasone is the first and only drug that has made a significant difference to patient mortality for COVID-19,” said Nick Cammack, COVID-19 therapeutics accelerator lead at the Wellcome Trust health charity”.

“Potentially preventing one death in every eight ventilated patients would be remarkable.”

“There is (now) realistic scope for further improving the clinical management of this devastating disease,” said Griffin, who was not involved in the study.

Cammack said that in light of the study results, dexamethasone “must now be rolled out and accessed by thousands of critically ill patients around the world.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top